
Investor Relations
PRESS RELEASES
May 24, 2022 Atmofizer Technologies Inc. Announces $1 per day clean air financing deal
May 12, 2022 Atmofizer Technologies Inc. Announces departures capital interview
April 29, 2022 Atmofizer Technologies Inc. announces year end 2021 financial results
April 5, 2022 Atmofizer Technologies Inc. Receives Patent from USPTO
March 22, 2022 Atmofizer Technologies Inc. Announced OTCQB Listing
March 10, 2022 Whit Pepper joins Atmofizer Technologies as President and Chief Commercial Officer
March 9, 2022 Atmofizer Technologies Inc. Receives Notice of Allowance from USPTO
February 23, 2022 Atmofizer Announces At-The-Market Offering of up to $5,000,000
January 31, 2022 Atmofizer Sponsored Car Wins at 24 Hours at Daytona
January 28, 2022 Atmofizer Technologies Inc. Files Financial Statements and MD&A
January 20, 2022 MIT Senior Researcher, Yuming Liu, Joins Atmofizer as Scientific Advisor
January 20, 2022 Atmofizer Technologies Inc. Provides Update
January 19, 2022 Atmofizer Technologies Inc. Unaware of Any Material Change
January 17, 2022 Kemper Confirms Successful Test of Atmofizer Technology Improving Industrial Fume Extraction
January 6, 2022 Atmofizer Announces Indoor Agriculture Testing for Mold Reduction
December 29, 2021 Atmofizer To Attend CES 2022 In Las Vegas
December 2, 2021 Atmofizer Technologies Inc. Signs Distribution Partnership with USA Rapid Test
November 30, 2021 Atmofizer Technologies Inc. Partners with Kemper GmbH to Disrupt a Global Fume Extraction and Filtration Industry
November 19, 2021 Atmofizer Technologies Inc. Provides Corporate Update – Harvard, MIT trained Physician Dr. Joshua Helman joins the Board of Directors
November 15, 2021 Atmofizer Technologies Inc. Announces Closing of Reverse Takeover Transaction
November 12, 2021 Listing Statement Atmofizer Technologies, Inc. in Connection with the Listing of the Shares of the Company (Formerly Known as Consolidated HCI Holdings Corporation)
550 Burrard Street
Suite 2300
Vancouver, BC V6C 2B5
Canada
+1.305.902.1858
info@ATMOfizer.com
Contact Information
BOARD OF DIRECTORS

Olivier Centner
Olivier has over 25 years building businesses in various industries. Notably, Mr. Centner is the founder of UNOapp, a leader in digital first solutions for retail-tech and consumer engagement. Working with over 2,000 retailers and Fortune 500 brands such as Coca-Cola, Monster Energy, Corby, Diageo.

Michael Galloro
Michael is principal at ALOE Finance, a Toronto based boutique transaction firm focused on the small/mid cap public markets space. He has quarterbacked numerous go public and M&A transactions across various industries operating globally and acts a director for public companies. Michael is a CPA.

Dr. Joshua Helman
Joshua is a Harvard-trained physician licensed in fourteen states. He is Board Certified by the American Board of Emergency Medicine and American Board of Lifestyle Medicine. He is the former Medical Director of Hippocrates Health Institute and is currently affiliated with TrueNorth Health Center.

Nareda Mills
Nareda has over 25 years’ experience in the Healthcare and Pharma industry in various leadership roles since receiving her degree as a Registered Nurse in Canada. Nareda began her clinical career at the John Hopkins All Children’s. Nareda is currently the President of the Global Patient Solutions business unit.

Peter Simeon
Peter has over 20 years of experience as a lawyer focused on securities, corporate finance, and mergers and acquisitions. Since February 2015 he has been a partner at Gowling WLG (Canada) LLP and has extensive experience in corporate commercial and securities law. Mr. Simeon acts as an independent director on several publicly traded companies in Canada.

Dr. Gregor Luthe
Gregor holds a PhD from University of Amsterdam in Chemistry and Toxicology.
Marie Curie fellowship for promising scientists European Community. Distinguished Feodor Lynen Fellowship of the Alexander von Humboldt Foundation.

Dr. Yuming Liu
Yuming is a scholar and has been working as the Sr. Research Scientist at MIT Department of Mechanical Engineering (MechE) for the past 23 years. Dr. Liu has a PhD from MIT in Marine Hydrodynamics. Dr. Liu has over 45 renowned publications in International Refereed Symposia.
SCIENTIFIC ADVISORY

Dr. Joshua Helman
Joshua is a Harvard-trained physician licensed in fourteen states. He is Board Certified by the American Board of Emergency Medicine and American Board of Lifestyle Medicine. He is the former Medical Director of Hippocrates Health Institute and is currently affiliated with TrueNorth Health Center.

